Effects of At2 Receptor Agonist Novokinin on Oxidative Stress, Inflammation and Infarct Size Due to Myocardial Ischemia-Reperfusion — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Effects of At2 Receptor Agonist Novokinin on Oxidative Stress, Inflammation and Infarct Size Due to Myocardial Ischemia-Reperfusion
Aim: Ischemia and reperfusion (IR) injury is a serious problem that is occured during thrombolytic therapy, organ transplantation, coronary angioplasty, and cardiopulmonary bypass. There is an increase in the number of AT2 receptors in some pathological conditions such as cardiac hypertrophy, myocardial infarction, congestive heart failure. This study was designed to investigate the effects AT2 receptor agonist Novokinin on infarct size, caveolin-1 (CAV-1), HSP90, ADMA, NADPH oxidase and Rhokinase associated to endothelial dysfunction and oxidative stress, and NFκB and TLR-4 levels induced by inflammation on myocardial IR. Methods: The experimental groups: Sham (C), Novokinin (N), IR and IRN. Novokinin was performed with infusion pump before ischemia, and during IR. The left main coronary artery was occluded for 30 minutes ischemia followed by 120 minutes reperfusion in anesthetized rats. CAV-1, HSP90, and NFκB levels were measured by the quantitative reverse transcriptase polymerase chain reaction (qRT-PCR), ADMA, TLR-4, NADPH oxidase, and Rhokinase levels were measured by ELISA, infarct size was measured by ImageJ, an image analysis software, in the heart tissue. Results: NFκB, HSP90, NADPH oxidase and TLR-4 levels increased with IR and significantly decreased with Novokinin. CAV-1 levels were not different between the groups. ADMA and Rhokinase levels were increased due to IR but decreased with Novokinin. Novokinin reduced infarct size due to IR. Conclusion: Our results showed that, ADMA, HSP90, NFκB, TLR-4, Rhokinase, and NADPH oxidase levels play important roles on IR injury. AT2 receptor agonist Novokinin may affect positively oxidative changes, inflammation, and endothelial function in myocardial IR injury.
Reiter, R.J. and Tan, D.X. (2003) Melatonin: A Novel Protective Agent against Oxidative Injury of the Ischemic-Reperfused Heart. Cardiovascular Research, 58, 10-19.
Lefer, D.J. and Granger, D.N. (2000) Oxidative Stress and Cardiac Disease. American Journal of Medicine, 109, 315-323.
Siemionow, M. and Arslan, E. (2004) Ischemia/Reperfusion Injury: A Review in Relation to Free Tissue Transfers. Microsurgery, 24, 468-475. https://doi.org/10.1002/micr.20060
Sydow, K. and Munzel, T. (2003) ADMA and Oxidative Stress. Atherosclerosis, 4, 41-51.
Beg, A., Sha, W.C., Bronson, R., Ghosh, S. and Baltimore, D. (1995) Embryonic Lethality and Liver Degeneration in Mice Lacking the RelA Component of NF-Kappa B. Nature, 376, 167-170. https://doi.org/10.1038/376167a0
Li, Y.W., Xie, G.R., Li, L., Jiang, Z.S., Yue, Z.S. and Pan, Z.Y. (2015) The Effect of TLR4/MyD88/NF-kB Signaling Pathway on Proliferation and Apoptosis in Human Nasopharyngeal Carcinoma 5-8F Cells Induced by LPS. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 11, 1012-1015.
Kupatt, C., Dessy, C., Hinkel, R., Raake, P., Daneau, G., Bouzin, C., Boekstegers, P. and Feron, O. (2004) Heat Shock Protein 90 Transfection Reduces Ischemia-Reperfusion-Induced Myocardial Dysfunction via Reciprocal Endothelial NO Synthase Serine 1177 Phosphorylation and Threonine 495 Dephosphorylation. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 1435-1441. https://doi.org/10.1161/01.ATV.0000134300.87476.d1
Jasmin, J.F., Rengo, G., Lymperopoulos, A., Gupta, R., Eaton, G.J., Quann, K., Gonzales, D.M., Mercier, I., Koch, W.J. and Lisanti, M.P. (2011) Caveolin-1 Deficiency Exacerbates Cardiac Dysfunction and Reduces Survival in Mice with Myocardial Infarction. American Journal of Physiology Heart and Circulatory Physiology, 300, 1274-1281. https://doi.org/10.1152/ajpheart.01173.2010
Takemoto, M., Sun, J., Hiroki, J., Shimokawa, H. and Liao, J.K. (2002) Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase. Circulation, 106, 57-62. https://doi.org/10.1161/01.CIR.0000020682.73694.AB
Maxwell, S.R. and Lip, G.Y. (1997) Reperfusion Injury: A Review of the Pathophy- siology, Clinical Manifestations and Therapeutic Options. International Journal of Cardiology, 58, 95-117.
Schwartzman, R.A. and Cidlowski, J.A. (1993) Apoptosis: The Biochemistry and Molecular Biology of Programmed Cell Death. Endocrine Review, 14, 133-150.
Reilly, P.M., Schiller, H.J. and Bulkley, G.B. (1991) Pharmacologic Approach to Tissue Injury Mediated by Free Radicals and Other Reactive Oxygen Metabolites. The American Journal of Surgery, 161, 488-503.
Kilinç, K. and Kilinç, A. (2002) Oksijen Toksisitesinin Araci Molekülleri Olarak Oksijen Radikalleri. Hacettepe Tip Dergisi, 33, 110-118.
Johnston, C.I. (1994) Tissue Angiotensin Converting Enzyme in Cardiac and Vascular Hypertrophy, Repair, and Remodeling Clinical Conference. Hypertension, 23, 258-268. https://doi.org/10.1161/01.HYP.23.2.258
Horiuchi, M., Akishita, M. and Dzau, V.J. (1999) Recent Progress in Angiotensin II Type 2 Receptor Research in the Cardiovascular System. Brief Review, 33, 613-621. https://doi.org/10.1161/01.hyp.33.2.613
Unger, T. (1999) The Angiotensin Type 2 Receptor: Variations on an Enigmatic Theme. Journal of Hypertension, 17, 1775-1786. https://doi.org/10.1097/00004872-199917121-00001
Ohinata, K., Fujiwata, Y., Shingo, F., Masaru, I., Masatsugu, H. and Yoshikawa, M. (2009) Orally Administered Novokinin, an Angiotensin AT2 Receptor Agonist, Suppresses Food Intake via Prostaglandin E2-Dependent Mechanism in Mice. Peptides, 30, 1105-1108.
Yamada, Y., Yamauchi, D., Usui, H., Zhao, H., Yokoo, M., Ohinata, K., Iwai, M., Horiuchi, M. and Yoshikawa, M. (2008) Hypotensive Activity of Novokinin, a Potent Analogue of Ovokinin(2-7), Is Mediated by Angiotensin AT(2) Receptor and Prostaglandin IP Receptor. Peptides, 29, 412-418.
Yamada, Y., Yamauchi, D., Yokoo, M., Ohinata, K., Usui, H. and Yoshikawa, M. (2008) Potent Hypotensive Peptide, Novokinin, Induces Relaxation by AT2- and IP-Receptor-Dependent Mechanism in the Mesenteric Artery from SHRs. Bioscience, Biotechnology, and Biochemistry, 72, 257-259. https://doi.org/10.1271/bbb.70638
Bond, M., Fabunmi, R., Baker, A. and Newby, A. (1998) Synergistic Upregulation of Metalloproteinase-9 by Growth Factors and Inflammatory Cytokines; An Absolute Requirement for Transcription Factor NF-Kappa B. FEBS Letters, 435, 29-34.
Vallejo, J.G. (2011) Role of Toll-Like Receptors in Cardiovascular Diseases. Clinical Science, 121, 1-10. https://doi.org/10.1042/CS20100539
Lorne, E., Zmijewski, J.W., Zhao, X., Liu, G., Tsuruta, Y., Park, Y.J., Dupont, H. and Abraham, E. (2008) Role of Extracellular Superoxide in Neutrophil Activation: Interactions between Xanthine Oxidase and TLR4 Induce Proinflammatory Cytokine Production. American Journal of Physiology: Cell Physiology, 294, 985- 993. https://doi.org/10.1152/ajpcell.00454.2007
Timmers, L., Sluijter, J.P., van Keulen, J.K., Hoefer, I.E., Nederhoff, M.G., Goumans, M.J., Doevendans, P.A., van Echteld, C.J., Joles, J.A., Quax, P.H., Piek, J.J., Pasterkamp, G. and de Kleijn, D.P. (2008) Toll-Like Receptor 4 Mediates Mal- Adaptive Left Ventricular Remodeling and Impairs Cardiac Function after Myocardial Infarction. Circulation Research, 102, 257-264. https://doi.org/10.1161/CIRCRESAHA.107.158220
Liu, C.C., Huang, Y., Zhang, J.H., Xu, Y. and Wu, C.H. (2013) Effect of Carvedilol on Cardiac Dysfunction 4 Days after Myocardial Infarction in Rats: Role of Toll-Like Receptor 4 and β-Arrestin 2. European Review for Medical and Pharmacological Sciences, 17, 2103-2110.
Paier, A., Agewall, S. and Kublickiene, K. (2009) Expression of Heat Shock Proteins and Nitrotyrosine in Small Arteries from Patients with Coronary Heart Disease. Heart Vessels, 24, 260-266. https://doi.org/10.1007/s00380-008-1117-y
Shi, Y., Hutchins, W. and Ogawa, H. (2005) Increased Resistance to Myocardial Ischemia in the Brown Norway vs. Dahl S Rat: Role of Nitric Oxide Synthase and Hsp90. Journal of Molecular and Cellular Cardiology, 38, 625-635.
Richter, B., Niessner, A., Penka, M., Grdic, M., Steiner, S., Strasser, B., Ziegler, S., Zorn, G., Maurer, G., Simeon-Rudolf, V., Wojta, J. and Huber, K. (2005) Endurance Training Reduces Circulating ADMA and MPO Levels in Persons at Risk of Coronary Events. Thrombosis and Haemostasis, 94, 1306-1311.
Valkonen, V.P., Päivä, H., Salonen, J.T., Lakka, T.A., Lehtimäki, T., Laakso, J. and Laaksonen, R. (2001) Risk of Acute Coronary Events and Serum Concentration of Asymmetrical Dimethylarginine. The Lancet, 358, 2127-2128.
Stühlinger, M.C., Conci, E., Haubner, B.J., Stocker, E.M., Schwaighofer, J., Cooke, J.P., Tsao, P.S., Pachinger, O. and Metzler, B. (2007) Asymmetric Dimethyl L-Arginine (ADMA) Is a Critical Regulator of Myocardial Reperfusion Injury. Cardiovascular Research, 75, 417-425.
Young, L.H., Ikeda, Y. and Lefer, A.M. (2001) Caveolin-1 Peptide Exerts Cardiopro- tective Effects in Myocardial Ischemia-Reperfusion via Nitric Oxide Mechanism. American Journal of Physiology Heart and Circulatory Physiology, 280, 2489-2495.
Chow, A.K., Daniel, E.E. and Schulz, R. (2010) Cardiac Function Is Not Significantly Diminished in Hearts Isolated from Young Caveolin-1 Knockout Mice. American Journal of Physiology Heart and Circulatory Physiology, 299, 1183- 1189. https://doi.org/10.1152/ajpheart.01195.2009
Li, J.M., Gall, N.P., Grieve, D.J., Chen, M. and Shah, A.M. (2002) Activation of NADPH Oxidase during Progression of Cardiac Hypertrophy to Failure. Hyper- tension, 40, 477-484. https://doi.org/10.1161/01.HYP.0000032031.30374.32
Fukui, T., Yoshiyama, M., Hanatani, A., Omura, T., Yoshikawa, J. and Abe, Y. (2001) Expression of p22phox and gp91phox, Essential Components of NADPH Oxidase, Increases after Myocardial Infarction. Biochemical and Biophysical Research Communications, 281, 1200-1206.
Qin, F., Simeone, M. and Patel, R. (2007) Inhibition of NADPH Oxidase Reduces Myocardial Oxidative Stres and Apoptosis and Improves Cardiac Function in Heart Failure after Myocardial Infarction. Free Radical Biology & Medicine, 43, 271-281.
Xiao, L., Pimentel, D.R., Wang, J., Singh, K., Colucci, W.S. and Sawyer, D.B. (2002) Role of Reactive Oxygen Species and NAD(P)H Oxidase in alpha(1)-Adrenoceptor Signaling in Adult Rat Cardiac Myocytes. American Journal of Physiology Heart and Circulatory Physiology, 282, 926-934. https://doi.org/10.1152/ajpcell.00254.2001
Dong, M., Yan, B.P., Liao, J.K., Lam, Y.Y., Yip, G.W. and Yu, C.M. (2010) Rho-Kinase Inhibition: A Novel Therapeutic Target for the Treatment of Car- diovascular Diseases. Drug Discovery Today, 15, 622-629.
Bao, W., Hu, E., Tao, L., Boyce, R., Mirabile, R., Thudium, D.T., Ma, X.L., Willette, R.N. and Yue, T.L. (2004) Inhibition of Rho-Kinase Protects the Heart against Ischemia/Reperfusion Injury. Cardiovascular Research, 61, 548-558.
Zhou, Q. and Liao, J.K. (2009) Rho Kinase: An Important Mediator of Athe- rosclerosis and Vascular Disease. Current Pharmaceutical Design, 15, 3108-3115. https://doi.org/10.2174/138161209789057986
Parlakpinar, H., Ozer, M.K. and Acet, A. (2011) Effects of Captopril and Angiotensin II Receptor Blockers (AT1, AT2) on Myocardial Ischemia-Reperfusion Induced Infarct Size. Cytokine, 56, 688-694.
Jehle, A.B., Xu, Y., Dimaria, J.M., French, B.A., Epstein, F.H., Berr, S.S., Roy, R.J., Kemp, B.A., Carey, R.M. and Kramer, C.M. (2012) A Nonpeptide Angiotensin II Type 2 Receptor Agonist Does Not Attenuate Postmyocardial Infarction Left Ventricular Remodeling in Mice. Journal of Cardiovascular Pharmacology, 59, 363- 368. https://doi.org/10.1097/FJC.0b013e3182444110